Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Barin Tumor Group phase II study 26972

Martin van den Bent; O-L Chinot; W Boogerd; J Bravo Marques; MJB Taphoorn; J.M. Kros; Karin van der Rijt; CJ Vecht; N De Beule; B Baron

doi:10.1093/annonc/mdg157

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Barin Tumor Group phase II study 26972

Martin van den Bent
, O-L Chinot
, W Boogerd
, J Bravo Marques
, MJB Taphoorn
, J.M. Kros
, Karin van der Rijt
, CJ Vecht
, N De Beule
, B Baron

Research output: Contribution to journal › Article › Academic › peer-review

163 Citations (Scopus)

47 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	599-602
Number of pages	4
Journal	Annals of Oncology
Volume	14
DOIs	https://doi.org/10.1093/annonc/mdg157
Publication status	Published - 2003

Research programs

EMC MM-03-24-03
EMC MM-03-44-06

Access to Document

10.1093/annonc/mdg157

12649108.pdfFinal published version, 63.9 KB

http://hdl.handle.net/1765/72892

Cite this

van den Bent, M., Chinot, O.-L., Boogerd, W., Bravo Marques, J., Taphoorn, MJB., Kros, J. M., van der Rijt, K., Vecht, CJ., De Beule, N., & Baron, B. (2003). Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Barin Tumor Group phase II study 26972. Annals of Oncology, 14, 599-602. https://doi.org/10.1093/annonc/mdg157

@article{40064793d8b04990bb550f224e11b80c,

title = "Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Barin Tumor Group phase II study 26972",

author = "\{van den Bent\}, Martin and O-L Chinot and W Boogerd and \{Bravo Marques\}, J and MJB Taphoorn and J.M. Kros and \{van der Rijt\}, Karin and CJ Vecht and \{De Beule\}, N and B Baron",

year = "2003",

doi = "10.1093/annonc/mdg157",

language = "Undefined/Unknown",

volume = "14",

pages = "599--602",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

}

van den Bent, M, Chinot, O-L, Boogerd, W, Bravo Marques, J, Taphoorn, MJB, Kros, JM, van der Rijt, K, Vecht, CJ, De Beule, N & Baron, B 2003, 'Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Barin Tumor Group phase II study 26972', Annals of Oncology, vol. 14, pp. 599-602. https://doi.org/10.1093/annonc/mdg157

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Barin Tumor Group phase II study 26972. / van den Bent, Martin; Chinot, O-L; Boogerd, W et al.
In: Annals of Oncology, Vol. 14, 2003, p. 599-602.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Barin Tumor Group phase II study 26972

AU - van den Bent, Martin

AU - Chinot, O-L

AU - Boogerd, W

AU - Bravo Marques, J

AU - Taphoorn, MJB

AU - Kros, J.M.

AU - van der Rijt, Karin

AU - Vecht, CJ

AU - De Beule, N

AU - Baron, B

PY - 2003

Y1 - 2003

U2 - 10.1093/annonc/mdg157

DO - 10.1093/annonc/mdg157

M3 - Article

SN - 0923-7534

VL - 14

SP - 599

EP - 602

JO - Annals of Oncology

JF - Annals of Oncology

ER -